Simulations Plus, Inc. (NASDAQ: SLP) is a Technology company in the Software - Application industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 46.10 | EPS (ttm) | 0.40 | Insider Own | 48.90% | Shs Outstand | 20.22M | Perf Week | 0.11% |
| Market Cap | 372.95M | Forward P/E | 17.40 | EPS next Y | 1.06 | Insider Trans | -0.49% | Shs Float | 16.81M | Perf Month | 0.44% |
| Enterprise Value | 355.95M | PEG | 2.32 | EPS next Q | 0.11 | Inst Own | - | Short Float | 16.88% | Perf Quarter | 1.04% |
| Income | 9.00M | P/S | 4.60 | EPS this Y | 126.25% | Inst Trans | - | Short Ratio | 6.84 | Perf Half Y | 58.56% |
| Sales | 81.00M | P/B | 2.02 | EPS next Y | 17.13% | ROA | 5.30% | Short Interest | 2.84M | Perf YTD | 1.15% |
| Book/sh | 9.15 | P/C | 20.72 | EPS next 5Y | 19.90% | ROE | 6.18% | 52W High | 21.01 -12.23% | Perf Year | 19.51% |
| Cash/sh | 0.89 | P/FCF | 14.29 | EPS past 3/5Y | - | ROIC | 5.32% | 52W Low | 11.09 66.28% | Perf 3Y | -54.97% |
| Dividend Est. | 0.24 (1.30%) | EV/EBITDA | 29.66 | Sales past 3/5Y | 13.52% 13.47% | Gross Margin | 63.38% | Volatility | 0.12% 0.15% | Perf 5Y | -59.19% |
| Dividend TTM | - | EV/Sales | 4.39 | EPS Y/Y TTM | -18.37% | Oper. Margin | 14.02% | ATR (14) | 0.04 | Perf 10Y | 100.87% |
| Dividend Ex-Date | Jul 29, 2024 | Quick Ratio | 5.54 | Sales Y/Y TTM | 15.71% | Profit Margin | 9.88% | RSI (14) | 64.51 | Recom | 2.56 |
| Dividend Gr. 3/5Y | -9.14% -5.59% | Current Ratio | 5.54 | EPS Q/Q | 105.88% | SMA20 | 0.14% | Beta | 1.30 | Target Price | 18.50 |
| Payout | 0.00% | Debt/Eq | 0.00 | Sales Q/Q | 10.00% | SMA50 | 0.51% | Rel Volume | 0.19 | Prev Close | 18.43 |
| Employees | 213 | LT Debt/Eq | 0.01 | Earnings | Oct 29 | SMA200 | 12.39% | Avg Volume | 363.05K | Price | 18.44 |
| IPO Date | Jun 18, 1997 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 9.38% 12.15% | Net Debt/EBITDA | -2.66 | Volume | 68,272 | Change | 0.05% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jun-18-26 | Reiterated | Craig-Hallum | Buy | $56 → $19 |
| Jun-17-26 | Downgrade | William Blair | Outperform → Market Perform | |
| Dec-18-25 | Downgrade | BTIG | Buy → Neutral | |
| Jul-15-25 | Downgrade | Keybanc | Overweight → Sector Weight | |
| Jul-29-24 | Reiterated | KeyBanc | $47 | |
| Jun-13-24 | Reiterated | Oppenheimer | Outperform | $67 → $65 |
| Jun-13-24 | Reiterated | Craig-Hallum | Buy | $56 |
| Jun-21-23 | Reiterated | Oppenheimer | Outperform | $67 |
| Oct-26-21 | Upgrade | Craig-Hallum | Hold → Buy | |
| Jan-12-21 | Downgrade | Craig-Hallum | Buy → Hold |
Simulations Plus, Inc. (SLP) is a worldwide developer of sophisticated software and services aimed at enhancing drug discovery and development processes. The company employs artificial intelligence and machine learning technologies to create tools for modeling, simulation, and predicting molecular characteristics. Its operations are divided into four main business units: Simulations Plus, Cognigen, DILIsym, and Lixoft. Among its diverse software offerings are GastroPlus, which models the absorption and drug interactions of compounds in both human and animal subjects, as well as DDDPlus and MembranePlus for various simulations. The company also provides a range of products built on mechanistic and mathematical models, such as its quantitative systems pharmacology software like DILIsym, NAFLDsym, IPFsym, RENAsym, and MITOsym. Furthermore, Simulations Plus offers the ADMET Predictor, a chemistry-focused computer program that forecasts molecular properties from structural inputs, alongside MedChem Designer, MonolixSuite, and PKPlus for additional modeling and simulation needs. Beyond software, the company extends its expertise through various services, including contract research for population modeling and simulation, specialized training and consultation to advance pharmacometrics studies, and clinical-pharmacology consulting to aid in regulatory submissions. Simulations Plus serves a broad spectrum of clients globally, including pharmaceutical, biotechnology, agrochemical, cosmetic, and food companies, as well as academic institutions and regulatory bodies. The company was founded in 1996 and maintains its headquarters in Lancaster, California.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 8/31/2025 | FY 2024 8/31/2024 | FY 2023 8/31/2023 | FY 2022 8/31/2022 | FY 2021 8/31/2021 | FY 2020 8/31/2020 | FY 2019 8/31/2019 | FY 2018 8/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 81 | 79 | 70 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 31 | 33 | 27 | — | — | — | — | — | — | |
| Gross Profit | 52 | 46 | 43 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 29 | 33 | 31 | — | — | — | — | — | — | |
| Research and Development | 11 | 7 | 6 | — | — | — | — | — | — | |
| Other Operating Expense | 1 | 77 | 0 | — | — | — | — | — | — | |
| Operating Income | 12 | -71 | 6 | — | — | — | — | — | — | |
| Interest Expense | 0 | 0 | 0 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 0 | 1 | 6 | — | — | — | — | — | — | |
| Net Income Before Taxes | 13 | -69 | 12 | — | — | — | — | — | — | |
| Income Taxes | 4 | -5 | 2 | — | — | — | — | — | — | |
| Consolidated Net Income | 9 | -65 | 10 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 9 | -65 | 10 | — | — | — | — | — | — | |
| Net Income | 9 | -65 | 10 | — | — | — | — | — | — | |
| EPS (Recurring) | 0.41 | -3.22 | 0.50 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.41 | -3.22 | 0.50 | — | — | — | — | — | — | |
| EPS (Diluted) | 0.40 | -3.22 | 0.49 | — | — | — | — | — | — | |
| EBITDA | 12 | 15 | 18 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 46.10 | — | 73.98 | — | — | — | — | — | — | |
| Price To Sales Ratio | 4.55 | 3.59 | 10.36 | — | — | — | — | — | — | |
| Gross Margin | 64.20 | 58.23 | 61.43 | — | — | — | — | — | — | |
| Operating Margin | 14.81 | -89.87 | 8.57 | — | — | — | — | — | — | |
| Net Margin | 11.11 | -82.28 | 14.29 | — | — | — | — | — | — | |
| Shares Outstanding | 20 | 20 | 20 | — | — | — | — | — | — | |
| Market Capitalization | 369 | 283 | 725 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| DiBella John Anthony II | Chief Revenue Officer | Aug 03 '26 | Sale | 18.28 | 1,000 | 18,280 | 85,140 | Aug 04 |
| DiBella John Anthony II | Chief Revenue Officer | Jul 06 '26 | Sale | 18.36 | 1,000 | 18,360 | 86,140 | Jul 08 |
| WOLTOSZ WALTER S | director, 10 percent owner: | Jul 01 '26 | Sale | 18.44 | 4,177 | 77,024 | 3,202,131 | Jul 06 |
| Fiedler-Kelly Jill | President, Services Solutions | Jun 16 '26 | Option Exercise | 10.05 | 7,350 | 73,868 | 85,167 | Jun 17 |
| Fiedler-Kelly Jill | President, Services Solutions | Jun 16 '26 | Sale | 18.20 | 7,350 | 133,770 | 77,817 | Jun 17 |
| Fiedler-Kelly Jill | President, Services Solutions | Jun 15 '26 | Sale | 16.51 | 1,050 | 17,336 | 77,817 | Jun 16 |
| Fiedler-Kelly Jill | President, Services Solutions | Jun 15 '26 | Option Exercise | 10.05 | 1,050 | 10,553 | 78,867 | Jun 16 |
| DiBella John Anthony II | Chief Revenue Officer | Jun 03 '26 | Sale | 16.50 | 1,000 | 16,500 | 87,140 | Jun 04 |
| WOLTOSZ WALTER S | director, 10 percent owner: | Jun 01 '26 | Sale | 17.43 | 15,000 | 261,450 | 3,252,800 | Jun 02 |
| Fiedler-Kelly Jill | President, Services Solutions | May 11 '26 | Option Exercise | 10.05 | 1,000 | 10,050 | 78,817 | May 13 |
| Fiedler-Kelly Jill | President, Services Solutions | May 11 '26 | Sale | 16.53 | 1,000 | 16,530 | 77,817 | May 13 |
| WOLTOSZ WALTER S | director, 10 percent owner: | May 04 '26 | Sale | 15.13 | 15,000 | 226,950 | 3,267,800 | May 05 |
| DiBella John Anthony II | Chief Revenue Officer | May 04 '26 | Sale | 14.98 | 1,000 | 14,980 | 88,140 | May 05 |
| DiBella John Anthony II | Chief Revenue Officer | Apr 15 '26 | Sale | 13.37 | 1,000 | 13,370 | 89,140 | Apr 16 |
| DiBella John Anthony II | Chief Revenue Officer | Feb 06 '26 | Option Exercise | 9.71 | 10,300 | 100,013 | 90,140 | Feb 09 |